Research reveals obesity's role in cancer development through mechanisms like chronic inflammation, hormonal disorders, and microbial dysbiosis. Lifestyle changes and targeted treatments hold potential in preventing obesity-related cancers.
Fecal microbiota transplantation (FMT) shows promise in enhancing cancer immunotherapy outcomes, with some studies demonstrating remarkable improvements and others showing no benefit. The success of FMT depends on multiple factors, including donor selection and specific bacterial communities being transferred.
Gemini achieved highest accuracy, followed by Claude-3-opus and GPT, with accuracy varying significantly across single-image tasks and continuous slices. Simplified prompts improved diagnostic performance, but Gemini and GPT struggled with normal image recognition.
A global study found that cancer immunotherapies carry a hidden risk: cholestasis, a serious liver condition. Researchers urge aggressive monitoring of liver function, particularly in younger adults and women.
A new study reveals that large language models can generate convincing but biased peer reviews, nearly indistinguishable from human writing. The AI excelled at generating persuasive rejection comments and fabricating reasons to cite unrelated studies, posing a serious risk to the integrity of scientific publishing.
A global analysis of CAR-T cell therapy found a significantly increased risk of developing secondary cancers, particularly T-cell lymphoma and myelodysplastic syndromes. The median onset of these cancers occurred much earlier in CAR-T recipients compared to those not receiving the treatment.
Senescent T cells exhibit genomic instability, protein imbalance, and mitochondrial dysfunction, impairing immune function and recognizing tumor antigens. The presence of senescent T cells is associated with poor prognosis and reduced immunotherapy efficacy.
This study uses AI to pinpoint optimal synergies in combination therapies, slashing experimental costs and accelerating discovery by up to 7.2% in accuracy.
Cancer-associated fibroblasts (CAFs) exhibit paradoxical effects on immunotherapy, sometimes hindering and other times helping to control tumors. Research identifies specific CAF subtypes that enhance or suppress immune cells, offering promising targets for therapies.
The CPADS web tool integrates data from GEO, TCGA, and GDSC databases to analyze gene expression changes, correlations between genes or drugs, and pathway enrichment in cancer samples. L1CAM was identified as a potential drug resistance target in non-small cell lung cancer through CPADS analysis.
Researchers find large language models (LLMs) can predict drug-target interactions more accurately. LLMs are advancing drug discovery by optimizing molecule design and improving model reliability.
Researchers map the path from liver fibrosis to cancer, revealing how scarred liver tissue becomes a breeding ground for tumor growth. Key findings include the role of hepatic stellate cells and dysregulated signaling pathways in remodeling the liver into a pro-tumor environment.
A new study uses GenAI models to extract pathological features for lung adenocarcinoma grading and prognosis, achieving striking accuracy and consistency. The research team discovered 11 key histological features and 4 clinical variables that provide a comprehensive risk assessment for patients.
The THER web tool analyzes hypoxia-associated transcriptomic data without programming skills, presenting results via volcano plots, heatmaps, and tables. Experimental validation confirms THER's reliability, revealing broad impacts of hypoxia on drug efficacy across tumor types.
The article discusses how intratumoral microbial metabolites modulate immune cell function, influencing cancer immunotherapy outcomes. The review examines the impact of glucose, amino acids, lipid, and other metabolites on the tumor microenvironment and immunotherapy efficacy.
State-of-the-art LLMs can assist radiologists in interpreting chest CT reports, reaching a 75% accuracy rate across common diseases. Fine-tuning and prompt engineering improve model performance, with GPT-4 and Qwen-Max showing exceptional strength.
Researchers develop machine learning models to analyze sparse digital footprints and forecast depressive relapses or manic episodes with clinical-level accuracy. The approach uses GPS-derived social withdrawal and erratic typing patterns to predict bipolar episodes 24 hours in advance.
Researchers used machine learning to analyze 3,430 drugs and identified 29 new lipid-lowering candidates. The predictions were validated using clinical data, mouse experiments, and molecular docking, offering a potential solution for patients with hyperlipidemia.
Researchers have developed a predictive tool that can identify patients with nasopharyngeal carcinoma most likely to benefit from radiotherapy. The model uses transcriptomic data and machine learning to evaluate 113 algorithm combinations, identifying an 18-gene signature associated with radiosensitivity.
Researchers have pinpointed six pivotal signaling pathways driving osteosarcoma progression, offering a roadmap for developing precision therapies. Targeting these pathways simultaneously may curb both primary growth and metastasis in osteosarcoma patients.
New research highlights TNF-α system's involvement in central nervous system disorders such as depression, narcolepsy, multiple sclerosis, Alzheimer's, and Parkinson's disease. The study reveals that psychotropic drugs may activate the TNF-α system through various mechanisms.
A comprehensive review in Current Molecular Pharmacology explores the mechanisms of hepatic ischemia-reperfusion injury (IRI) and emerging treatments. Effective strategies include antioxidant administration, surgical preconditioning, and herbal compounds with anti-inflammatory and antioxidant properties.
A groundbreaking study found significant mitochondrial cardiolipin dysregulation in patients with bortezomib-induced peripheral neuropathy. The researchers identified diosmin as a promising candidate for targeting this condition, providing new avenues for therapeutic intervention.
A new study developed an innovative dynamic biomarker system to identify 'tipping points' in thyroid cancer progression and subtypes. The system, TCPSLevel, captures early-warning molecular signals and outperforms traditional staging in identifying high-risk individuals.
A new study reveals B cell-derived ELL2 as a promising biomarker for diagnosing and predicting the prognosis of sepsis. The research identified three subtypes with significantly different prognoses, which were consistently reproduced across all cohorts.
The new GseaVis package offers highly customizable visualizations, including enrichment plots, ranked gene heatmaps, and circular layouts, addressing the limitations of existing tools. It integrates seamlessly with established R libraries and workflows, making it accessible to researchers at various skill levels.
The rcssci package simplifies complex data relationships by introducing innovative RCS plot styles and adjustable knot numbers for enhanced statistical clarity. This enables researchers to explore and present their data with greater precision, leading to more accurate models for predicting disease risk.
Breakthroughs in treating age-related macular degeneration (AMD) include FDA-approved pegcetacoplan and avacincaptad pegol, targeting the complement system to slow geographic atrophy progression. Anti-VEGF therapies like faricimab also offer extended dosing intervals, reducing injection frequency.
The study explores the technological evolution of surgical robots and their current clinical applications. Surgical robots have addressed challenges in operating within small anatomical spaces, improving medical efficiency, but also increasing costs and complexity of operations.
Researchers developed IOBR to analyze interactions between tumors and immune systems, offering precision medicine and new therapeutic targets. The tool's capabilities include multi-omics data integration and visualization, enabling a deeper understanding of the tumor microenvironment.
A global study finds that COVID-19 had a disproportionate impact on communities with limited resources, including rural, low-income, or underserved areas. The research highlights the importance of high-resolution data to identify vulnerable populations and inform targeted interventions.
Researchers discovered a rare case where two cancer-related mutations coexisted in a woman with FAP and a history of endometrial cancer. This case may reveal new insights into how different genetic mutations can cooperate to promote cancer development.
The study reveals diverse microbial profiles within different tumor types, with notable diversity in species composition and spatial localization. Functional effects of intratumoral microbiota on the tumor microenvironment range from immunostimulatory to protumor.
This special issue focuses on cutting-edge advancements in polypharmacology for cancer therapy, addressing mechanisms of drug resistance and rational design of drug combinations. It also covers computational and AI-driven methodologies for discovering novel polypharmacological agents.
Current Molecular Pharmacology seeks talented young professionals for its editorial board. The journal focuses on cellular and molecular pharmacology advancements, genomics, proteomics, and drug action mechanisms.
Current Pharmaceutical Analysis seeks ambitious individuals to join its young editorial board, promoting pharmaceutical analysis development and enhancing academic influence. The journal focuses on multidimensional explorations in pharmaceutical analysis and pharmacological research.
The study highlights the challenges of commercializing renewable polymers, but also emphasizes the potential of chemical modification to improve their properties for clinical use. The research aims to provide a comprehensive overview of these sustainable materials in biomedical practice.
The journal Current Pharmaceutical Analysis (CPA) has seen a significant increase in its impact factor, doubling from the previous year to 1.5. This achievement indicates a substantial boost in the average impact of each published paper, attracting more top-tier research findings.
Current Molecular Pharmacology's 2024 Impact Factor increased to 2.9, advancing to the Q2 zone in PHARMACOLOGY & PHARMACY. The journal has achieved notable recognition and influence in its field.